Literature DB >> 11134131

Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.

B Biondi1, E A Palmieri, S Fazio, C Cosco, M Nocera, L Saccà, S Filetti, G Lombardi, F Perticone.   

Abstract

To determine the clinical impact of endogenous subclinical hyperthyroidism, specific symptoms and signs of thyroid hormone excess and quality of life were assessed in 23 patients (3 males and 20 females; mean age, 43 +/- 9 yr) and 23 age-, sex-, and lifestyle-matched normal subjects by using the Symptoms Rating Scale and the Short Form 36 Health Survey questionnaires. Because the heart is one of the main target organs of the thyroid hormone, cardiac morphology and function were also investigated by means of standard 12-lead electrocardiogram (ECG), 24-h Holter ECG, and complete Doppler echocardiography. Stable endogenous subclinical hyperthyroidism had been diagnosed in all patients at least 6 months before the study (TSH, 0.15 +/- 0.1 mU/L; free T(3), 6.9 +/- 1.1, pmol/L; free T(4), 17.2 +/- 2.3, pmol/L). Fifteen patients were affected by multinodular goiter, and eight patients by autonomously functioning thyroid nodule. The mean Symptoms Rating Scale score (9. 8 +/- 5.5 vs. 4.3 +/- 2.2, P: < 0.001) and both the mental (36.1 +/- 9.5 vs. 50.0 +/- 8.5, P: < 0.001) and physical (42.6 +/- 8.0 vs. 55. 6 +/- 4.1, P: < 0.001) component scores of Short Form 36 Health Survey documented a significant prevalence of specific symptoms and signs of thyroid hormone excess and notable impairment of quality of life in patients. Holter ECG showed a higher prevalence of atrial premature beats in endogenous subclinical hyperthyroid patients than in the controls, but the difference was not statistically significant, although the average heart rate was significantly increased in the patients (P: < 0.001). An increase of left ventricular mass (162 +/- 24 vs. 132 +/- 22 g, P: < 0.001) due to the increase of septal (P: = 0.025) and posterior wall (P: = 0.004) thickness was observed in patients. Systolic function was enhanced in patients as shown by the significant increase of both fractional shortening (P: = 0.005) and mean velocity of heart rate-adjusted circumferential fiber shortening (P: = 0.036). The Doppler parameters of diastolic function were significantly impaired in the patients as documented by the reduced early to late ratio of the transmitral flow velocities (P: < 0.001) and the prolonged isovolumic relaxation time (P: = 0.006). These data indicate that endogenous subclinical hyperthyroidism has a relevant clinical impact and that it affects cardiac morphology and function. Moreover, they suggest that treatment of persistent endogenous subclinical hyperthyroidism should be considered also in young and middle-aged patients to attenuate specific symptoms and signs of thyroid hormone excess, ameliorate the quality of life, and avoid the consequences to the heart of long exposure to a mild excess of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134131     DOI: 10.1210/jcem.85.12.7085

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  77 in total

1.  Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism.

Authors:  Abdulkadir Kırış; Cihangir Erem; Gülhanım Kırış; Mustafa Koçak; Omer Gedikli; Irfan Nuhoğlu; Merih Kutlu; Tuba Kaplan; Mustafa Gökçe; Sükrü Celik
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 2.  Thyroid hormone and blood pressure regulation.

Authors:  Sara Danzi; Irwin Klein
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

3.  Myocardial ultrastructure in cardiac hypertrophy induced by thyroid hormone--an acute study in rats.

Authors:  Li Wen Hu; Edson Aparecido Liberti; Maria Luiza Morais Barreto-Chaves
Journal:  Virchows Arch       Date:  2005-01-25       Impact factor: 4.064

Review 4.  Overview of the management of differentiated thyroid cancer.

Authors:  Jyotika K Fernandes; Terry A Day; Mary S Richardson; Anand K Sharma
Journal:  Curr Treat Options Oncol       Date:  2005-01

Review 5.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

6.  How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study.

Authors:  F Vaisman; C Medina Coeli; L S Ward; H Graf; G Carvalho; R Montenegro; M Vaisman
Journal:  J Endocrinol Invest       Date:  2013-01-14       Impact factor: 4.256

7.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01

Review 8.  Subclinical hyperthyroidism: to treat or not to treat?

Authors:  E H Hoogendoorn; M den Heijer; A P J van Dijk; A R Hermus
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

9.  Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Authors:  Susanna C Larsson; Elias Allara; Amy M Mason; Karl Michaëlsson; Stephen Burgess
Journal:  Circ Genom Precis Med       Date:  2019-03

10.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.